Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness products under the Invibe MD name; anti-aging products under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. The company was incorporated in 2017 and is headquartered in Vancouver, Canada. Ovation Science Inc. operates as a subsidiary of Skinvisible Pharmaceuticals, Inc.…
Ovation Science (CNSX: OVAT) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.
The shares were at 0.0200 CAD on 19 November 2026, down 42.9% over 52 weeks. Its 52-week range is 0.0150 CAD to 0.0500 CAD: the price is 60.0% below the high and 33.3% above the low.
Its market capitalisation is 768.83K CAD.
Ovation Science reports return on equity of 43.3% and revenue down 50.8% year over year.
Its debt exceeds its cash by 278.93K CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.